• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Small Cap High Growth Stocks
151 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

OSE

OSE Immunotherapeutics
€5.52-7.5%36.3%€119.1m€7.15PS53.5xE92.9%n/a

NEWBRY

Newbury Pharmaceuticals
kr3.41-2.3%-40.2%kr82.7mkr8.00PS3.6xE112.9%n/a

ADOC

Adocia
€8.36-3.7%192.3%€119.5m€9.70PS19.7xE104.5%n/a

GTHX

G1 Therapeutics
US$3.72-9.3%20.8%US$208.7mUS$8.50PS2.4xE55.1%n/a

ZVRA

Zevra Therapeutics
US$4.55-0.4%-13.7%US$189.2mUS$19.00PS6.9xE63.6%n/a

APLT

Applied Therapeutics
US$4.31-2.3%139.4%US$489.0mUS$11.60PS49.3xE81.9%n/a

RCEL

AVITA Medical
US$8.722.0%-44.4%US$219.8mUS$25.90PS4.5xE62.0%n/a

CLBIO

Corline Biomedical
kr10.55-2.8%0.5%kr226.7mkr32.00PS6.4xE71.1%n/a

ACR

Acrux
AU$0.0611.7%10.9%AU$17.7mn/aPS1.6xE115.3%0%

SPAGO

Spago Nanomedical
kr0.3618.4%-54.9%kr80.9mn/aPS13.6xE54.4%n/a

XBRANE

Xbrane Biopharma
kr0.21-11.5%-99.8%kr318.1mn/aPS1.3xE98.0%n/a

DVYSR

Devyser Diagnostics
kr102.00-0.5%18.1%kr1.7bkr128.96PS9.8xE101.6%n/a

ALDVI

Advicenne
€1.63-4.5%-57.0%€20.0m€6.90PS6.1xE118.1%n/a

EGTX

Egetis Therapeutics
kr5.87-6.2%-34.2%kr1.7bkr13.13PS29.8xE85.4%n/a

A216080

JETEMA
₩15,670.002.0%-21.7%₩279.8b₩28,000.00PE20xE38.9%n/a

STX

Shield Therapeutics
UK£0.013-5.3%-81.6%UK£10.6mn/aPS1.8xE89.2%n/a

IPH

Innate Pharma
€2.233.0%-14.2%€180.3m€6.27PS2.9xE33.0%n/a

BIOVIC B

Biovica International
kr1.60-22.4%-77.9%kr134.3mkr15.00PS19.3xE83.0%n/a

A206650

EuBiologics
₩13,760.001.5%91.4%₩502.0b₩15,000.00PS7.2xE93.4%n/a

NWRN

Newron Pharmaceuticals
CHF7.646.4%72.1%CHF142.3mCHF13.01PS16.1xE53.3%n/a

ALONC

Oncodesign Société Anonyme
€14.420%57.3%€99.4m€18.64PS3xE101.2%n/a

2552

Hua Medicine (Shanghai)
HK$1.643.1%-46.2%HK$1.6bHK$3.13PS19.4xE83.3%n/a

2315

Biocytogen Pharmaceuticals (Beijing)
HK$8.9214.4%-64.1%HK$3.6bHK$15.39PS4.6xE100.1%n/a

688136

Kexing Biopharm
CN¥16.4612.6%-21.7%CN¥3.3bCN¥30.55PS2.6xE126.8%0%
Page 1 of 7
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.